KWALITY PHARMACEUTICALS LIMITED

Scale -

Revenue is 503 Rs Cr; Annual Growth is 36 %; Continuous Growth over 3 years
Ebitda is 121 Rs Cr; Annual Growth is 47 %; Continuous Growth over 3 years
PBT is 33.99 Rs Cr; Annual Growth is 65 %; Continuous Growth over 3 years; 5 Year CAGR is -14 %
PAT is 67.35 Rs Cr; Annual Growth is 69 %; Continuous Growth over 3 years; 5 Year CAGR is -13 %
Quarterly Revenue is 162 Rs Cr; Continuous Growth over 3 Quarters

Profitability -

PAT Margin is 13.38 %; Annual Growth is 24 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is -16 %
PBDIT Margin is 24.07 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is -11 %
Quarterly Ebitda Margin is 25 %; Continuous Growth over 3 Quarters; in Top Quartile

Return -

ROA is 11.37 %; Annual Growth is 28 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is -25 %
ROE is 20.35 %; Annual Growth is 35 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is -26 %
ROCE is 27.62 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is -23 %
Asset Turnover is 97 %; Continuous Growth over 3 years; in Top Quartile

Efficiency -

Inventory Turnover Ratio is 6.22; Annual Growth is 36 %; Continuous Growth over 3 years
Current Ratio is 1.8; Continuous Growth over 3 years
Quick Ratio is 1.45; Continuous Growth over 3 years

Operating cash flow is 16.59 Rs Cr; Annual Decline is -69 %; 5 Year CAGR is -29 %

Solvancy -

Debt/Equity is 0.39; Continuous Decline over 3 years

Long term Debt is 29.4 Rs Cr; Annual Growth is 94 %; in Top Quartile
Total Debt is 130 Rs Cr; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 32 %
Contingent Liabilities is 36.98 Rs Cr; 5 Year CAGR is 421 %

Quality -

Change in Inventories/Total Expenses is 0 %; Annual Decline is -82 %
Other Expenses/Total Expenses is 17 %; Continuous Decline over 3 years

Operating cashflow/ebitda is 14 %; Annual Decline is -79 %; in Bottom Quartile; 5 Year CAGR is -22 %
Operating cashflow/PAT is 25 %; Annual Decline is -81 %; Continuous Decline over 3 years; 5 Year CAGR is -18 %

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem

Sector

Major Subsidiaries/Associates

Key Clients

Products

Products

Product details

Operations

Capacity/ Production

Key Facilities

Key Certifications

Raw materials

Search: